New findings could lead to better treatment for blood cancer
Which medicine is best when you are affected by cancer? This can vary from person to…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Collaborators highlights global trends in risk factors linked to lung cancer deaths
Even though lung and related cancer deaths decreased in the world’s 10 most populous countries…
New drug hope for prostate cancer patients
Prostate cancer that has become resistant to hormone therapy could be treated using a new…
Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer
Colorectal cancer (CRC) is a global health concern, and despite advances in radiotherapy, endogenous radioresistance…
Study identifies potential new target to overcome breast cancer resistance
A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA…
ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric leukaemias
A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows…
ASH 2024: Smoking linked with genetic mutations that worsen myelodysplastic syndromes
For the first time, researchers have illuminated how smoking – a known risk factor for…
ASH 2024: A fibre-rich diet may help prevent complications after stem cell transplant
Consuming a high-fiber diet after undergoing stem cell transplantation could help to reduce the risk…
ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia
Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug…
Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumour progression
The COVID-19 pandemic and recent Nobel Prize recognition have spotlighted mRNA therapies as a promising…